Blue Cloud Softech Share Price Surges for the Third Consecutive Day
The small-cap IT stock, Blue Cloud Softech, has extended its winning streak to the third day, rising by 2.39% to ₹25.64 per share during the intraday session on Thursday, December 11.
A Strong Rally in the Past Five Sessions
Over the past five sessions, the stock has seen a significant surge of nearly 22%. However, in the near term, the share price trend has been negative, with an 11.50% decline in a month and a 56.27% drop in the last year.
A Wealth-Creating Machine for Long-Term Investors
Despite the short-term volatility, Blue Cloud Softech has proven to be a multibagger stock, giving returns of 350% over the last five years, making it a wealth-creating machine for its long-term investors.
What's Behind the Rally?
The company's strong three-day surge is driven by its fundraising plans and AI-focused growth strategy. Blue Cloud Softech has secured in-principle approval from BSE to issue 31,68,00,000 equity shares at ₹23.06 each via preferential allotment.
Global Expansion Strategy
The company has announced a major global expansion strategy aimed at the $957.30-billion addressable market across 56 Commonwealth countries. The plan focuses on scaling its AI-driven healthcare platforms, including BluBio, BluHealth, and Bioster.
Recent Contract Wins
Blue Cloud Softech has also secured a sizeable ₹110.8-crore contract for Data Annotation and AI Training Services from US-based Stratos Forge Inc. The company's order book is strengthening, with a net profit of ₹15 crore in the September quarter, up from ₹11 crore in Q2FY25.
Key Highlights
- 7.6% annual rise in operating revenue to ₹253 crore
- 350% returns over the last five years
- Ai-focused growth strategy driving the company's expansion
Please note that this story is for educational purposes only, and investors should consult with an investment advisor before making any investment decisions.